These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 27761165)

  • 1. Catheter ablation for ventricular tachyarrhythmia in patients with channelopathies.
    Murakoshi N; Aonuma K
    J Arrhythm; 2016 Oct; 32(5):404-410. PubMed ID: 27761165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter Ablation for Channelopathies: When Is Less More?
    Mehta A; Chandiramani R; Ghosh B; Asatryan B; Hajra A; Barth AS
    J Clin Med; 2024 Apr; 13(8):. PubMed ID: 38673656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ventricular tachycardia in the absence of structural heart disease.
    Srivathsan K; Lester SJ; Appleton CP; Scott LR; Munger TM
    Indian Pacing Electrophysiol J; 2005 Apr; 5(2):106-21. PubMed ID: 16943951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter and Device Management of Inherited Cardiac Conditions.
    Bennett R; Campbell T; Kumar S
    Heart Lung Circ; 2020 Apr; 29(4):594-606. PubMed ID: 32014423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventional electrophysiology and its role in the treatment of cardiac arrhythmia.
    Teo WS; Kam R; Tan A
    Ann Acad Med Singap; 1998 Mar; 27(2):248-54. PubMed ID: 9663319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term outcome after cardioverter-defibrillator implantation in patients with Brugada syndrome].
    Binbin Y; Jingping L; Bing Y; Minglong C; Jiangang Z; Kejiang C; Qijun S
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Aug; 43(8):690-4. PubMed ID: 26955725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.
    AbdelWahab A; Sapp J
    Curr Cardiol Rep; 2017 Sep; 19(11):105. PubMed ID: 28900864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S; Haverkamp W; Borggrefe M; Breithardt G; Bocker D
    Europace; 2009 Mar; 11(3):289-96. PubMed ID: 19095687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms and clinical management of inherited channelopathies: long QT syndrome, Brugada syndrome, catecholaminergic polymorphic ventricular tachycardia, and short QT syndrome.
    Kaufman ES
    Heart Rhythm; 2009 Aug; 6(8 Suppl):S51-5. PubMed ID: 19631908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F; Jarman JW; Clague JR; Till J
    Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.
    Kottkamp H; Hindricks G; Chen X; Brunn J; Willems S; Haverkamp W; Block M; Breithardt G; Borggrefe M
    Circulation; 1995 Sep; 92(5):1159-68. PubMed ID: 7648661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): a multicentre randomised controlled trial.
    Kuck KH; Schaumann A; Eckardt L; Willems S; Ventura R; Delacrétaz E; Pitschner HF; Kautzner J; Schumacher B; Hansen PS;
    Lancet; 2010 Jan; 375(9708):31-40. PubMed ID: 20109864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of subcutaneous implantable cardioverter-defibrillator performance in patients with ion channelopathies from the EFFORTLESS cohort and comparison with a meta-analysis of transvenous ICD outcomes.
    Lambiase PD; Eckardt L; Theuns DA; Betts TR; Kyriacou AL; Duffy E; Knops R
    Heart Rhythm O2; 2020 Dec; 1(5):326-335. PubMed ID: 34113890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias].
    Ohnishi S; Kasanuki H
    J Cardiol; 2000 Mar; 35 Suppl 1():75-84. PubMed ID: 10834174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.
    Elliott PM; Sharma S; Varnava A; Poloniecki J; Rowland E; McKenna WJ
    J Am Coll Cardiol; 1999 May; 33(6):1596-601. PubMed ID: 10334430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arrhythmogenic right ventricular cardiomyopathy. Antiarrhythmic drugs, catheter ablation, or ICD?
    Wichter T; Paul TM; Eckardt L; Gerdes P; Kirchhof P; Böcker D; Breithardt G
    Herz; 2005 Mar; 30(2):91-101. PubMed ID: 15875097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping and ablation of ventricular fibrillation-how and for whom?
    Willems S; Hoffmann BA; Schaeffer B; Sultan A; Schreiber D; Lüker J; Steven D
    J Interv Card Electrophysiol; 2014 Sep; 40(3):229-35. PubMed ID: 24626997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency catheter ablation for unifocal premature ventricular complexes triggering recurrent ventricular fibrillations in a young man without structural heart disease.
    Cho YR; Park JS
    Korean Circ J; 2012 Aug; 42(8):575-9. PubMed ID: 22977457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.